NCT00007735

Brief Summary

In 1990 and 1991, the U.S. deployed approximately 700,000 troops to the Persian Gulf to liberate Kuwait from Iraqi occupation. While there were few casualties associated with the Gulf War, many individuals returned from this conflict with unexplained symptoms and illnesses. This constellation of symptoms has been termed Gulf War Veterans' Illnesses (GWI). Although several explanations have been offered as to the cause of GWI, none of the putative etiologic agents or conditions is currently supported by sufficient evidence. One explanation that has received fairly widespread attention is systemic Mycoplasma fermentans infection. It is the purpose of this study to determine if antibiotic treatment directed against Mycoplasma species (i.e. doxycycline) will improve functioning and symptoms in deployed Gulf War veterans with GWI.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Jan 1999

Typical duration for phase_3

Geographic Reach
2 countries

27 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1999

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 29, 2000

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 1, 2001

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2001

Completed
Last Updated

October 30, 2023

Status Verified

February 1, 2007

First QC Date

December 29, 2000

Last Update Submit

October 26, 2023

Conditions

Keywords

antibiotic treatmentmycoplasma speciesGulf War Veterans' Illnesses (GWI)mycoplasma positiveGulf War Syndrome

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
All veterans deployed to the Gulf War between August, 1990 and August, 1991 having at least two of the following symptoms: Fatigue, musculoskeletal pain or neurocognitive dysfunction. Mycoplasma positive

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (27)

Vamc - Birmingham, Al

Birmingham, Alabama, 35233, United States

Location

Naval Health Research Center Merchant Illness Divi

San Diego, California, 92152, United States

Location

Uniformed Services University Department of Psychi

Washington D.C., District of Columbia, 20307-5001, United States

Location

Vamc - Augusta, Ga

Augusta, Georgia, 30904-6285, United States

Location

Vamc - Hines,Il

Hines, Illinois, 60141, United States

Location

Vamc - New Orleans, La

New Orleans, Louisiana, 70146, United States

Location

Vamc - Boston, Ma

Boston, Massachusetts, 02130, United States

Location

Vamc - Omaha, NE

Omaha, Nebraska, 68105, United States

Location

Vamc - Manchester,Nh

Manchester, New Hampshire, 03103, United States

Location

Vamc - East Orange, Nj

East Orange, New Jersey, 07018, United States

Location

Vamc - Albuquerque, Nm

Albuquerque, New Mexico, 87108, United States

Location

Vamc - Albany, Ny

Albany, New York, 12208, United States

Location

Vamc - Brooklyn, Ny

Brooklyn, New York, 11209, United States

Location

Vamc - Bronx,Ny

The Bronx, New York, 10468, United States

Location

Vamc - Durham, Nc

Durham, North Carolina, 27705, United States

Location

Vamc - Fargo, Nd

Fargo, North Dakota, 58102-2498, United States

Location

Vamc - Dayton, Oh

Kettering, Ohio, 45429, United States

Location

Vamc - Oklahoma City, Ok

Oklahoma City, Oklahoma, 73104, United States

Location

Vamc - Philadelphia, Pa

Philadelphia, Pennsylvania, 19104, United States

Location

Vamc - Providence, Ri

Providence, Rhode Island, 02908-4799, United States

Location

Vamc - Charleston, Sc

Charleston, South Carolina, 29401-5799, United States

Location

Vamc - Nashville, Tn

Nashville, Tennessee, 37212-2637, United States

Location

Vamc - Houston, Tx

Houston, Texas, 77030-4298, United States

Location

Vamc - White River Junction

White River Junction, Vermont, 05009, United States

Location

Vamc - Richmond, Va

Richmond, Virginia, 23249, United States

Location

Vamc - Milwaukee, Wi

Milwaukee, Wisconsin, 53295, United States

Location

Vamc - San Juan, Pr

San Juan, 00927, Puerto Rico

Location

MeSH Terms

Conditions

Persian Gulf SyndromeMycoplasma Infections

Interventions

Doxycycline

Condition Hierarchy (Ancestors)

Occupational DiseasesWar-Related InjuriesWounds and InjuriesMycoplasmatales InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections

Intervention Hierarchy (Ancestors)

TetracyclinesNaphthacenesPolycyclic Aromatic HydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Intervention Model
PARALLEL
Sponsor Type
FED

Study Record Dates

First Submitted

December 29, 2000

First Posted

January 1, 2001

Study Start

January 1, 1999

Study Completion

October 1, 2001

Last Updated

October 30, 2023

Record last verified: 2007-02

Locations